4-(Bromoacetyl)-5-methyl-3-phenylisoxazole → HCID 24738992, compound
Reaction equation
Br[CH2:2][C:3]([C:5]1[C:6]([C:11]2[CH:16]=[CH:15][CH:14]=[CH:13][CH:12]=2)=[N:7][O:8][C:9]=1[CH3:10])=O.[NH2:17][C:18]1[CH:23]=[CH:22][C:21]([F:24])=[CH:20][N:19]=1>>[F:24][C:21]1[CH:22]=[CH:23][C:18]2[N:19]([CH:2]=[C:3]([C:5]3[C:6]([C:11]4[CH:16]=[CH:15][CH:14]=[CH:13][CH:12]=4)=[N:7][O:8][C:9]=3[CH3:10])[N:17]=2)[CH:20]=1Participants
3
Procedure
As described for Example 2, 4-(bromoacetyl)-5-methyl-3-phenylisoxazole (commercially available) (112 mg, 0.4 mmol) was converted, using 2-amino-5-fluoropyridine instead of 2-amino-3-methylpyridine, to the title compound (15 mg, 13%) which was obtained as a yellow solid. MS: m/e=294.3 [M+H]+.
Sources & evidence
- ORD record
- ord-5ae639013ced40b7819a119cbae6af95
- Source dataset
- uspto-grants-2009_09
- Patent number
- US07585874B2
Reaction notes
Loading…